News archive

The Swedish Society for Virology has awarded the Pandemifonden Fenyö Prize for 2024 to Daniel Sheward, Assistant Professor at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS. The study has been published in the journal PNAS and led by researchers at Karolinska Institutet, Sweden, and Stanford University School of Medicine, USA.

When you hear the words mucus and snot, you might think of colds, snails or drooling babies. But the runny, sometimes sticky substance often plays a vital role in our lives. And mucus also has potential to be a medicine.

On 26 November an experiment in a sounding rocket was launched at Esrange Space Center in Kiruna, Sweden by a research group at the Department of Microbiology, Tumor and Cell Biology (MTC) at Karolinska Institutet. The researchers aims to collect data for a study that examines how a type of immune cell, T cells, are affected by lack of gravity, called microgravity.

The Committee for Research at Karolinska Institutet has decided on recipients from the Jonas Söderquist scholarship foundation for basic research in virology and immunology. The awarded are Benjamin Nilsson Payant at the Department of Microbiology, Tumor and Cell Biology and Egle Kvedaraite at the Department of Medical Biochemistry and Biophysics.

Is your immune system functioning as it should? The question is not as simple to answer as one might think. Professor Petter Brodin is trying to understand more about it. At the same time, he hopes to help patients that are severely affected with post-COVID and other conditions where the regulation of the immune system is not working.

Unrestrained inflammation is associated with many diseases, including cardiovascular diseases, autoimmune diseases and cancer. Peder Olofsson wants to understand how nerve signals regulate inflammation to ultimately improve therapeutic options. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 3 October.

A third of the Swedish population lives with a chronic inflammatory skin disease, such as psoriasis, eczema and vitiligo. Liv Eidsmo is mapping the skin’s T cells to better understand why the diseases often recur at the same place. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 3 October.

In a recent study published in Nature, Swedish researchers demonstrate the role of sex hormones in regulating the immune system. This newfound knowledge explains differences between men and women and can be used to develop new immunological medications according to researchers.

Acute respiratory infections are one of the most common reasons for medical treatment in Sweden and a major cause of morbidity and mortality. Anna Smed Sörensen hopes that a better understanding of the immune system in the airways will make serious disease preventable. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 3 October.

Many immunodeficiency diseases are serious conditions that require stem cell transplantation. Lisa Westerberg is studying how mutations prevent immune cells from moving properly in order to find new therapeutic strategies. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 3 October.

Together with researchers from University of Oxford, researchers at Karolinska Institutet have demonstrated that a subclass of stem cells that are dedicated to the production of platelets replenish platelets through a distinct and shorter pathway than other stem cells. This is presented in a study published in the journal Nature Immunology.

A new study from Karolinska Institutet reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings, published in Nature Cardiovascular Research, suggest that the response to the onset of atherosclerosis begins in the liver.

Lisa Westerberg has been appointed Professor of Experimental Immunology at the Department of Microbiology, Tumor and Cell Biology from 1 January 2024.

After half a century in near-Earth orbit, humans are heading further out in space. First to the moon again. Then on to Mars! For this to go well, more research is needed on how space stresses the human body.

A new method, developed at Karolinska Institutet, KTH Royal Institute of Technology and SciLifeLab, can identify unique immune cell receptors and their location in tissue, a study published in the journal Science reports. The researchers predict that the method will improve the ability to identify which immune cells contribute to disease processes and open up opportunities to develop novel therapies for numerous diseases.

A new study from Karolinska Institutet published in Cell reports shows that tumor-associated macrophages, which are white blood cells that are found in breast tumors, can both help and hinder the spread of cancer cells to other organs. The researchers found that macrophages that produce a substance called VEGF-C reduce the spread of breast cancer to the lungs but increase the spread to the lymph nodes. This may have implications for the prognosis and treatment of breast cancer.

Alexandra Argyriou, doctoral student at the Department of Medicine, Solna and Mireia Cruz De los Santos, doctoral student at the Department of Oncology and Pathology, have been awarded the Cilla Weigelt Scholarship for outstanding research in molecular mechanisms related to rare and under-treated diseases. The scholarships, 50,000 SEK each, will be awarded on November 13.

The Committee for Research at Karolinska Institutet has decided on recipients from the Jonas Söderquist scholarship foundation for basic research in virology and immunology.

Meet Anna Smed Sörensen, research group leader at the Division of Immunology and Allergy, Department of Medicine, Solna.

Researchers at Karolinska Institutet and the University of Oslo present a new type of immunotherapy that attacks cancer cells with a specific mutation. A study published in the journal Nature Cancer shows promising effects on patient cells in mice and offers hope for patients with acute myeloid leukaemia (AML), a cancer that has proven difficult to treat.

The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis. Now, an article published in Science Immunology by researchers from Karolinska Institutet challenges this hypothesis by showing that mice with high infectious exposures from birth have the same, if not an even greater ability to develop allergic immune responses than 'clean' laboratory mice.

The government has appointed Jan Albert, professor of infectious disease control at Karolinska Institutet and senior consultant at Karolinska University Hospital, to lead a government inquiry looking into strengthening the country’s preparedness for future pandemics. The directive concerns a national strategy for how pandemics are to be managed and a possible revision of the Communicable Diseases Act. The investigation should be delivered in February 2025.

A new study led by researchers at Karolinska Institutet has examined how T cells of the immune system are affected by weightlessness. The results, which are published in the journal Science Advances, could explain why astronauts’ T cells become less active and less effective at fighting infection.

Vaccination protects against severe COVID-19 but not against infection. Researchers at Karolinska Institutet and Danderyd Hospital now show that protection against infection with the new omicron variants is linked to mucosal IgA antibodies, which are not induced by vaccination. These are the findings of two studies recently published in The Lancet Infectious Diseases, and The Lancet Microbe, and could explain the limited protection by currently available vaccines against infection.

A new study in Nature by an international team including researchers at Karolinska Institutet has identified the first genetic variant associated with disease severity in multiple sclerosis. The finding opens the door to the development of treatments that fight disease progression – a great unmet need facing people with MS.

Assistant professor Marcus Buggert at Karolinska Institutet is awarded Anders Jahre's prize for young researchers 2023 and 400.000 NOK.

Our skin contains specialised long-lived killer cells that protect against intruders. Researchers at Karolinska Institutet and the University of Copenhagen have now identified how these cells are formed, and shown that high levels of memory killer cells in cancer tissue correlate with a better survival rate in people with melanoma. The study is published in the journal Immunity.

Jenny Mjösberg at the Department of Medicine in Huddinge at Karolinska Institutet, receives the 2023 Eric K. Fernström Prize for young, promising and successful researchers, for her outstanding research on the role of innate lymphoid cells in various diseases.

Vaccines against smallpox given until the mid-1970s offer continuing cross-reactive immunity to mpox (previously known as monkeypox), researchers from Karolinska Institutet report in a study published in the scientific journal Cell Host & Microbe.

Researchers at Karolinska Institutet have found further evidence for how the Epstein-Barr virus can trigger multiple sclerosis or drive disease progression. A study published in Science Advances shows that some individuals have antibodies against the virus that mistakenly attack a protein in the brain and spinal cord.

Researchers from Karolinska Institutet and Sachs’ Children and Youth Hospital have mapped the immune system in the gut of children with inflammatory bowel disease (IBD). The results, which were published in Cell Reports Medicine, can be used to design more targeted therapies.

Acetylcholine regulates blood flow, but the source of blood acetylcholine has been unclear. Now, researchers at Karolinska Institutet have discovered that certain T cells in human blood can produce acetylcholine, which may help regulate blood pressure and inflammation. The study, which is published in PNAS, also demonstrates a possible association between these immune cells in seriously ill patients and the risk of death.

Immunotherapy is an effective form of therapy for different types of cancer. However, for pancreatic cancer, its effect is limited and differs between men and women. Researchers at Karolinska Institutet have now found a possible explanation for this sex difference. The study, which is published in Cancer Research, reveals the presence of an immune cell in women with pancreatic cancer that obstructs the body’s immune response. The results can pave the way for a more sex-specific treatment.

During the pandemic, it became clear that children who contracted COVID-19 became less ill than adults. One hypothesis has been that common colds would give children immunity protecting against a severe form of the disease. Researchers at Karolinska Institutet are now able to show that OC43, one of the coronaviruses that cause common colds, boosts the immune response to COVID-19. The study, which is published in PNAS, could give rise to more tailored vaccine programmes for children and adults.

Jenny Mjösberg, Professor of Tissue Immunology at Karolinska Institutet, is one of five researchers to be awarded the Göran Gustafsson Prize this year. The prize is intended for young researchers in medicine, molecular biology, chemistry, physics and mathematics and is awarded by the Göran Gustafsson Foundations in collaboration with the Royal Swedish Academy of Sciences.

The first detailed description of the microbiota and immune cells among asymptomatic Helicobacter pylori-infected individuals has been published by researchers at Karolinska Institutet. The results of the study will be instrumental to understand the complex microbiome and immunity network and provide new insights for asymptomatic Helicobacter pylori infection.

PhD student Pradeepa Pushparaj, in Gunilla Karlsson Hedestam’s group at the Department of Microbiology, Tumor and Cell Biology, is the first author of a study recently published in Immunity. The study explains how antibody genes can influence the ability to make neutralizing antibodies to SARS-CoV-2.

High levels of mucosal IgA antibodies in the airways protect against SARS-CoV-2 infection for at least eight months. Omicron infection generates durable mucosal antibodies, reducing the risk of re-infection. These are the findings of a study published in The Lancet Infectious Diseases by researchers at Karolinska Institutet and Danderyd Hospital in Sweden. The results raise further hope for the feasibility of future nasal vaccine platforms to protect against infection.

Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint inhibitor. This is according to a new study published in Cancer Immunology Research by researchers at Karolinska Institutet.

The nanomaterial graphene oxide—which is used in everything from electronics to sensors for biomolecules—can indirectly affect the immune system via the gut microbiome, as shown in a new study on zebrafish by researchers at Karolinska Institutet. The findings are reported in the journal Nature Nanotechnology.

B cells are critical to the proper functioning of the immune system. However, researchers at Karolinska Institutet have shown that they can sometimes do more harm than good, as their numbers greatly increase after bowel damage, preventing the tissue from healing. The results, which are presented in the journal Immunity, can be of significance to the treatment of inflammatory bowel disease.

By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease may progress according to a study from Karolinska Institutet published in Nature Communications.

Researchers at Karolinska Institutet have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease. The findings, which are presented in Frontiers in Immunology, indicate that IL-26 is a potential biomarker for severe COVID-19.  

The Committee for Research at Karolinska Institutet has decided on recipients from the Jonas Söderquist scholarship foundation for basic research in virology and immunology 2022. Quirin Hammer at the Department of Medicine, Huddinge (MedH) and Daniel Sheward at the Department of Microbiology, Tumor- and Cell Biology (MTC)) are awarded.

Four research projects coordinated from Karolinska Institutet have been awarded project grants by Knut and Alice Wallenberg Foundation (KAW) in 2022. This means that, over SEK 135 million are allocated to KI research in the fields of immunology, neuroscience, and stem cell biology.

A study at Karolinska Institutet shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments. The findings, published in the journal The Lancet Infectious Diseases, suggest a risk of increased SARS-CoV-2 infections this winter, unless the new updated bivalent vaccines help to boost immunity in the population.

Lower immunity and recurring infections are common in type 1 and type 2 diabetes. Researchers at Karolinska Institutet now show that the immune system of people with diabetes has lower levels of the antimicrobial peptide psoriasin, which compromises the urinary bladder’s cell barrier, increasing the risk of urinary tract infection. The study is published in Nature Communications.

In a new analysis, Karolinska Institutet is ranked number eight in a list of organizations with the most published articles on COVID-19 and the immune response. KI also stands out as one of the universities that has had the most international collaborations in the field. The analysis was conducted by Chinese researchers without a connection to KI and is published in the journal Frontiers in Public Health.

Researchers at Karolinska Institutet present the results of a refined clinical COVID-19 test, which has been used to track the spread of the Omicron variant in real time in the Swedish population. The study, published in the journal Med, provides new insights into the dominance transition of Omicron sublineages that occurred consistently across the world.